Antioxidant, anti-inflammatory and hepatoprotective effects of silymarin on hepatic dysfunction induced by sodium nitrite.
OBJECTIVE
Sodium nitrite, a food additive that is used as a color fixative and preservative for meats and fish, has been reported to have adverse health effects due to increased oxidative stress that could be harmful to different organs including the liver. Meanwhile, silymarin protects against hepatotoxicity caused by a variety of agents, on account of its antioxidative and anti-inflammatory effects. We therefore examined the impact of dietary silymarin on sodium nitrite-induced liver damage in rats.


METHODS
Fifty adult male Sprague-Dawley rats received 80 mg/kg sodium nitrite in the presence or absence of silymarin (10 and 25 mg/kg). Hepatic proinflammatory cytokines (TNF-α and IL-1β), hepatic fibrosis marker (MCP-1 and TGF-β1), mitochondrial activity marker (cytochrome C oxidase) and c-reactive protein (CRP) levels were measured. Hepatic apoptosis was assessed through determination of caspase-3 activity and DNA fragmentation.


RESULTS
We found that oral sodium nitrite enhanced oxidative stress with subsequent increases in TNF-α (2-fold), IL-1β (4-fold), MCP-1 (4-fold), TGF-β1 (3-fold) and CRP (4-fold). In addition, sodium nitrite brings about reduced cytochrome C oxidase and enhanced caspase-3 activity and DNA fragmentation. Daily treatment with silymarin markedly ameliorated all these effects.


CONCLUSIONS
Silymarin ameliorated the impairment of hepatic function in rats that had ingested sodium nitrite. Silymarn possesses antioxidant, anti-inflammatory, antifibrotic and anti-apoptotic effects.
Dept. of Clinical Biochemistry, Faculty of Pharmacy, University of Mansoura, Mansoura, 35516, Egypt.
Imam O
IO
Sherif
Mohammed M H
MM
Al-Gayyar
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy*; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012838:Silymarin / Q000627:therapeutic use*; D012977:Sodium Nitrite / Q000633:toxicity*
D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D012838:Silymarin; D012977:Sodium Nitrite
CRP; DNA fragmentation; IL-1β; MCP-1; TGF-β1 and TNF-α; caspase-3; cytochrome C oxidase; sodium nitrite